The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 216, Issue suppl_3, Pages S452-S457
Publisher
Oxford University Press (OUP)
Online
2017-06-02
DOI
10.1093/infdis/jix239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid Detection ofFKS-Associated Echinocandin Resistance in Candida glabrata
- (2016) Yanan Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method
- (2016) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory
- (2016) C. Wattal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Rapid Detection and Identification of Candidemia by Direct Blood Culturing on Solid Medium by Use of Lysis-Centrifugation Method Combined with Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (MALDI-TOF MS)
- (2016) Evgeny A. Idelevich et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds
- (2016) Ana Espinel-Ingroff et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- The epidemiology and outcomes of invasiveCandidainfections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
- (2016) David R. Andes et al. Transplant Infectious Disease
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
- (2016) Kelley R. Healey et al. Nature Communications
- Mechanisms of echinocandin antifungal drug resistance
- (2015) David S. Perlin Annals of the New York Academy of Sciences
- Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation
- (2015) Dimitrios Farmakiotis et al. CLINICAL MICROBIOLOGY AND INFECTION
- The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality
- (2015) Emily Wang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quick Detection ofFKS1Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans
- (2015) Catiana Dudiuk et al. JOURNAL OF CLINICAL MICROBIOLOGY
- First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States
- (2015) Nathan P. Wiederhold et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antifungal drug resistance amongCandidaspecies: mechanisms and clinical impact
- (2015) Maurizio Sanguinetti et al. MYCOSES
- Community participation in biofilm matrix assembly and function
- (2015) Kaitlin F. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emergence of Azole Resistance in Aspergillus
- (2015) Nathan Wiederhold et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
- (2014) Fernando César Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms
- (2014) Anuradha Chowdhary et al. Future Microbiology
- Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
- (2014) Michael A. Pfaller et al. PLoS One
- Fungal Biofilms, Drug Resistance, and Recurrent Infection
- (2014) J. V. Desai et al. Cold Spring Harbor Perspectives in Medicine
- Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency offksMutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
- (2013) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida
- (2013) L. Ostrosky-Zeichner CLINICAL INFECTIOUS DISEASES
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Azole resistance in Aspergillus fumigatus
- (2013) Edith Vermeulen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination viaIn VivoPharmacodynamic Evaluation against Candida glabrata with and withoutfksMutations
- (2012) Alexander Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
- (2012) M. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mouldAspergillus fumigatus
- (2012) Paul E Verweij et al. PEST MANAGEMENT SCIENCE
- Resistance to echinocandins comes at a cost
- (2012) Ronen Ben-Ami et al. Virulence
- Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts
- (2011) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia
- (2011) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MALDI-TOF MS in microbiological diagnostics—identification of microorganisms and beyond (mini review)
- (2011) Andreas Wieser et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- CandidaBloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
- (2010) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
- (2010) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
- (2010) John W. Baddley et al. CLINICAL INFECTIOUS DISEASES
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
- (2009) Paul E Verweij et al. LANCET INFECTIOUS DISEASES
- Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia
- (2008) J. W. Baddley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatus
- (2008) G. Garcia-Effron et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
- (2008) Eveline Snelders et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started